Anemia: An early complication of chronic renal insufficiency

American Journal of Kidney Diseases

Volumn 38, Issue 4, 2001, Pages 803-812

  Kazmi, Waqar H ^a,b   Kausz, Annamaria T ^a,b   Khan, Samina ^a,b   Abichandani, Rekha ^a,b   Ruthazer, Robin ^a,b   Obrador, Gregorio T ^a,b   Pereira, Brian J G ^a,b  

^a TUFTS MEDICAL CENTER   (United States)

^b UNIVERSIDAD PANAMERICANA   (Mexico)

Author keywords

Anemia; Chronic renal insufficiency (CRI); Glomerular filtration rate (GFR); Hematocrit (Hct); Recombinant human erythropoietin (rHuEPO)

Indexed keywords

CREATININE; IRON; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN;

ADULT; AGED; ANEMIA; ARTICLE; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HEMATOCRIT; HUMAN; HYPERTENSION; INTERSTITIAL NEPHRITIS; IRON DEFICIENCY; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT EDUCATION; RETROSPECTIVE STUDY;

EID: 0034816679     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2001.27699     Document Type: Article

References (32)

1. Erythropoietin and anemia in chronic renal failure
2. Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency
3. Prevalence of and factors associated with sub-optimal care prior to initiation of dialysis in the United States
4. Comorbid conditions and correlations with mortality risk among 3, 399 incident hemodialysis patients
5. Impact of left ventricular hypertrophy on survival in end-stage renal disease
6. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy
7. Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention
8. Hematocrit level and associated mortality in hemodialysis patients
9. Hematocrit levels and hospitalization risk in hemodialysis patients
10. Effect of recombinant human erythropoietin on hospital admissions, readmissions, length of stay, and costs of dialysis patients
11. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation
12. Recent developments and future issues in the use of health status assessment measures in clinical setting
13. Comorbidity assessment in hemodialysis and peritoneal dialysis using the index of coexistent disease
14. DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure
15. Biochemical parameters in chronic renal failure
16. Relationship between hematocrit and renal function in men and women
17. Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients
18. Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failure
19. The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin
20. The long-term effects of recombinant human erythropoietin on the cardiovascular system
21. Cardiovascular effects of recombinant human erythropoietin in predialysis patients
22. Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure
23. The use of recombinant human erythropoietin in predialysis patients
24. How to improve survival in predialysis patients
25. Consensus statement: Morbidity and mortality of dialysis
26. Prevalence, predictors and consequences of late nephrology referral at a tertiary care center
27. Iron storage in chronic uremic undialyzed patients
28. Hyporesponsiveness to erythropoietin
29. Intravenous iron supplementation for the anemia of moderate to severe chronic renal failure patients not receiving dialysis
30. Recombinant human erythropoietin treatment in predialysis patients: A double-blind, placebo-controlled trial
31. Effectiveness and safety of recombinant human erythropoietin in predialysis patients
32. Intravenous iron for the treatment of predialysis anemia